Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene

Human Genetics

Volumn 106, Issue 4, 2000, Pages 425-431

  Hes, Frederik J ^a   Zewald, Richard A ^a   Peeters, Ton ^a   Sijmons, Rolf H ^b   Links, Thera P ^c   Verheij, Joke ^b   Matthijs, Gert ^d   Legius, Eric ^d   Mortier, Geert ^e   Van Der Torren, Kors ^f   Rosman, Malou L ^g   Lips, Cornelis J M ^a   Pearson, Peter L ^a   Van Der Luijt, Rob B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f Merwede Ziekenhuis   (Netherlands)

^g IJsselmeer Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 3P; CLINICAL ARTICLE; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE SEQUENCE; GENOTYPE; HEMANGIOBLASTOMA; HUMAN; MALE; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTHERN BLOTTING; VON HIPPEL LINDAU DISEASE;

EID: 0034066439     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390000265     Document Type: Article

References (26)

1. Bradley JF, Rothberg PG (1999) Processed pseudogene from the von Hippel-Lindau disease gene is located on human chromosome 1. Diagn Mol Pathol 8:101-106
2. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Hofler H, Latif F, Lerman MI, Zbar B, Neumann HP (1995) Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 95:551-556
3. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, et al (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66-75
4. Cybulski C, Krzystolik K, Maher ER, Richard S, Kurzawski G, Gronwald J, Lubinski J (1999) Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene. Hum Genet 105:333-336
5. Decker HJ, Klauck SM, Lawrence JB, McNeil J, Smith D, Gemmill RM, Sandberg AA, Neumann HH, Simon B, Green J, et al (1994) Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL). Cancer Genet Cytogenet 77:1-13
6. Glavac D, Neumann HP, Wittke C, Jaenig H, Masek O, Streicher T, Pausch F, Engelhardt D, Plate KH, Hofler H, Chen F, Zbar B, Brauch H (1996) Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 98:271-280
7. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85-90
8. Hes FJ, Feldberg MA (1999) Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses). Eur Radiol 9:598-610
9. La Vecchia C, Negri E, D'Avanzo B, Franceshi S (1990) Smoking and renal cell carcinoma. Cancer Res 50:5231-5233
10. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou FW, Li H, Wei MH, Chen F, Glenn GM, Choyke PL, Walther MM, Weng Y, Duan DR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson Smith MA, Paslier ID, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320
11. Maher ER, Kaelin WG Jr (1997) Von Hippel-Lindau disease. Medicine (Baltimore) 76:381-391
12. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson Smith MA, Morton N (1991) Von Hippel-Lindau disease: a genetic study. J Med Genet 28:443-447
13. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT (1996) Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 33:328-332
14. Melmon KL, Rosen SW (1964) Lindau's disease: review of the literature and study of a large kindred. Am J Med 36:595-617
15. Muscat JE, Hoffmann D, Wynder EL (1995) The epidemiology of renal cell carcinoma. A second look. Cancer 75:2552-2557
16. Pack SD, Zbar B, Pak E, Ault DO, Humphrey JS, Pham T, Hurley K, Weil RJ, Park WS, Kuzmin I, Stolle C, Glenn G, Liotta LA, Lerman MI, Klausner RD, Linehan WM, Zhuang Z (1999) Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res 59:5560-5564
17. Phipps ME, Maher ER, Affara NA, Latif F, Leversha MA, Ferguson Smith ME, Nakamura Y, Lerman M, Zbar B, Ferguson Smith MA (1993) Physical mapping of chromosome 3p25-p26 by fluorescence in situ hybridisation (FISH). Hum Genet 92: 18-22
18. Richards FM, Phipps ME, Latif F, Yao M, Crossey PA, Foster K, Linehan WM, Affara NA, Lerman MI, Zbar B, et al (1993) Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 2:879-882
19. Stebbins CE, Kaelin WG Jr, Pavletich NP (1999) Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284:455-461
20. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R, Linehan WM (1998) Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:417-423
21. 39 thalassemic transcripts in cell-free extracts. Blood 70:293-300
22. Szymanski SC, Hummerich H, Latif F, Lerman MI, Rohrborn G, Schroder E (1993) Long range restriction map of the von Hippel-Lindau gene region on human chromosome 3p. Hum.Genet. 92: 282-288
23. Tyers M, Willems AR (1999) One ring to rule a superfamily of E3 ubiquitin ligases [comment]. Science 284: 601, 603-4
24. Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, Linehan WM (1999) Renal cancer in families with hereditary renat cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161: 1475-9
25. Webster AR, Richards FM, MacRonald FE, Moore AT, Maher ER (1998) An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet 63: 1025-35
26. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson Smith MA, Brauch H, Glavac D, Neumann HPH, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CJM, Linehan WM, Lerman M (1996) Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe and Japan. Hum Mutat 8:348-357